Reports

The November midterm election results in the U.S. House of Representatives were a clear rejection of President Trump’s tax and economic policies that favor the wealthy and corporations over working families. Prior to the November vote, pollsters for the Republican National Committee found that the GOP had “lost the messaging battle on the [tax] issue.” […]

READ FULL REPORT HERE In Congress, Rep. Rod Blum (R-IA) is an original cosponsor of a resolution declaring the national debt “a threat to national security.”  On her website, Rep. Mimi Walters (R-CA) says, “Our national debt is not only a threat to our financial security it is also a threat to our national security.” On his website, Rep. Erik […]

KEY FINDINGS “Republicans lost the messaging battle on the [tax] issue, per a Sept. 2 polling memo prepared for the Republican National Committee. Their poll found that by 61% to 30%, voters said the law benefits “large corporations and rich Americans” over “middle class families.” The memo attributed this to message discipline from the tax […]

Eight months since the tax cuts were passed in December 2017, here’s what the data show: Corporate profits up, corporate tax revenues down (Figure 1): In the second quarter of 2018 (six months after the tax cuts passed in December 2017), corporate after-tax profits were 16% higher than a year earlier in the second quarter […]

Our national and state-by-state reports about Medicare and Medicaid, in honor of its 53rd Anniversary. National Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York […]

View the Full Report in PDF here. TOPLINES The report examines the profits, taxes, and drug prices of the 10 biggest U.S. pharmaceutical companies, the “Pharma Big 10”: Johnson & Johnson, Pfizer, Merck & Co., Gilead Sciences, AbbVie, Amgen, Eli Lilly & Co., Bristol-Myers Squibb, Biogen and Celgene. Between 2011 and 2015, the Pharma Big 10 […]

Press Release: New Report: Taxpayer-Supported Gilead Sciences Is Price Gouging the Public, Then Dodging Taxes on the Huge Profits 7/13/2016 ATF Report Highlights: Gilead Sciences: Prices Gouger, Tax Dodger 7/13/2016 Full Report in PDF 7/13/2016 Shareable graphics on the Gilead report click here. Irish Media Confirms ATF Claims About Gilead Science’s Massive Profit Shifting 8/22/2016 Huffington Post Piece on […]

Pfizer, one of the world’s largest pharmaceutical companies and more profitable companies, is attempting to permanently dodge tens of billions of dollars of U.S. taxes it currently owes through a merger with fellow drug firm Allergan, based in the tax haven of Ireland. While technically not a corporate inversion, this maneuver will provide Pfizer with […]

Pfizer, one of the world’s largest pharmaceutical companies, has announced that it has entered into preliminary discussions with the Irish corporation Allergan to effect a business combination, which most observers assume would be structured as an “inversion” transaction. An inversion would allow Pfizer to renounce its U.S. tax citizenship while retaining its current U.S. headquarters, management structure […]

How the World’s Biggest Corporation Secretly Uses Tax Havens to Dodge Taxes A groundbreaking report reveals that Walmart has built a vast, undisclosed network of 78 subsidiaries and branches in 15 overseas tax havens, which may be used to minimize foreign taxes where it has retail operations and to avoid U.S. tax on those foreign […]